Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative routes for allergen-specific immunotherapy

G Passalacqua1, G W Canonica

  • 1Department of Internal Medicine, Genoa University, Italy.

Journal of Investigational Allergology & Clinical Immunology
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic rhinosinusitis with nasal polyposis and biological agents: the ARIA-ITALY survey.

European annals of allergy and clinical immunology·2024
Same author

Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?

Allergy·2024
Same author

Severe chronic rhinosinusitis treated with dupilumab, a real-life analysis of early effectiveness.

European review for medical and pharmacological sciences·2023
Same author

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

Allergy·2023
Same author

Concomitant Celiac Disease and Wheat Allergy: 2 Case Reports.

Journal of investigational allergology & clinical immunology·2019
Same author

When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation

European annals of allergy and clinical immunology·2019

Alternative routes for allergen immunotherapy, including oral and sublingual methods, offer a safer and more convenient alternative to injections for treating respiratory allergies, especially in children.

Area of Science:

  • Immunology
  • Allergy and Clinical Immunology
  • Pharmacology

Background:

  • Traditional allergen-specific immunotherapy (ASIT) involves injections, which can cause side effects and compliance issues.
  • Alternative routes like oral, sublingual, and intranasal immunotherapy aim to improve patient convenience and reduce adverse events.
  • Numerous studies have validated the efficacy and safety of these alternative ASIT methods for common inhalant allergens.

Purpose of the Study:

  • To evaluate the clinical efficacy and safety of alternative allergen-specific immunotherapy routes.
  • To compare the suitability of oral, sublingual, and intranasal immunotherapy for different patient populations.
  • To assess the overall benefits, including tolerability and socioeconomic advantages, of non-injectory ASIT.

Main Methods:

Related Experiment Videos

  • Review of controlled studies demonstrating clinical efficacy and safety of alternative ASIT routes.
  • Analysis of patient suitability based on administration techniques and compliance factors.
  • Assessment of tolerability, safety, and socioeconomic benefits.

Main Results:

  • Alternative routes (oral, sublingual, intranasal) show demonstrated clinical efficacy and safety for inhalant allergens.
  • Oral routes are particularly suitable for children and patients with poor compliance.
  • Nasal immunotherapy requires careful selection of well-trained adult patients due to administration technique.

Conclusions:

  • Alternative routes for allergen immunotherapy offer good tolerability and safety.
  • These non-injectory methods present significant socioeconomic benefits.
  • Alternative routes are supported as valid therapeutic options for managing respiratory allergies.